ANDA 77018, held by Fougera Pharmaceuticals. Metronidazole.
As of Nov 21, 2026, ANDA 77018 (Metronidazole), held by Fougera Pharmaceuticals, was first approved by FDA on Jun 6, 2006, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 6, 2006 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metronidazole0.75% · gel;topical | Metronidazole | Rx |
| Mar 28, 2012 | Supplement 3Labeling | Approved | None posted |
| Jun 6, 2006 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters